Impact of extent of resection for recurrent glioblastoma on overall survival

Clinical article

Orin Bloch Departments of Neurological Surgery and

Search for other papers by Orin Bloch in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Seunggu J. Han Departments of Neurological Surgery and

Search for other papers by Seunggu J. Han in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Soonmee Cha Radiology, University of California, San Francisco, California

Search for other papers by Soonmee Cha in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Matthew Z. Sun Departments of Neurological Surgery and

Search for other papers by Matthew Z. Sun in
Current site
Google Scholar
PubMed
Close
 B.S.
,
Manish K. Aghi Departments of Neurological Surgery and

Search for other papers by Manish K. Aghi in
Current site
Google Scholar
PubMed
Close
 M.D., Ph.D.
,
Michael W. McDermott Departments of Neurological Surgery and

Search for other papers by Michael W. McDermott in
Current site
Google Scholar
PubMed
Close
 M.D.
,
Mitchel S. Berger Departments of Neurological Surgery and

Search for other papers by Mitchel S. Berger in
Current site
Google Scholar
PubMed
Close
 M.D.
, and
Andrew T. Parsa Departments of Neurological Surgery and

Search for other papers by Andrew T. Parsa in
Current site
Google Scholar
PubMed
Close
 M.D., Ph.D.
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $536.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $636.00
USD  $45.00
USD  $536.00
USD  $636.00
Print or Print + Online Sign in

Object

Extent of resection (EOR) has been shown to be an important prognostic factor for survival in patients undergoing initial resection of glioblastoma (GBM), but the significance of EOR at repeat craniotomy for recurrence remains unclear. In this study the authors investigate the impact of EOR at initial and repeat resection of GBM on overall survival.

Methods

Medical records were reviewed for all patients undergoing craniotomy for GBM at the University of California San Francisco Medical Center from January 1, 2005, through August 15, 2009. Patients who had a second craniotomy for pathologically confirmed recurrence following radiation and chemotherapy were evaluated. Volumetric EOR was measured and classified as gross-total resection (GTR, > 95% by volume) or subtotal resection (STR, ≤ 95% by volume) after independent radiological review. Overall survival was compared between groups using univariate and multivariate analysis accounting for known prognostic factors, including age, eloquent location, Karnofsky Performance Status (KPS), and adjuvant therapies.

Results

Multiple resections were performed in 107 patients. Fifty-two patients had initial GTR, of whom 31 (60%) had GTR at recurrence, with a median survival of 20.4 months (standard error [SE] 1.0 months), and 21 (40%) had STR at recurrence, with a median survival of 18.4 months (SE 0.5 months) (difference not statistically significant). Initial STR was performed in 55 patients, of whom 26 (47%) had GTR at recurrence, with a median survival of 19.0 months (SE 1.2 months), and 29 (53%) had STR, with a median survival of 15.9 months (SE 1.2 months) (p = 0.004). A Cox proportional hazards model was constructed demonstrating that age (HR 1.03, p = 0.004), KPS score at recurrence (HR 2.4, p = 0.02), and EOR at repeat resection (HR 0.62, p = 0.02) were independent predictors of survival. Extent of initial resection was not a statistically significant factor (p = 0.13) when repeat EOR was included in the model, suggesting that GTR at second craniotomy could overcome the effect of an initial STR.

Conclusions

Extent of resection at recurrence is an important predictor of overall survival. If GTR is achieved at recurrence, overall survival is maximized regardless of initial EOR, suggesting that patients with initial STR may benefit from surgery with a GTR at recurrence.

Abbreviations used in this paper:

EOR = extent of resection ; GBM = glioblastoma ; GTR = gross-total resection ; KPS = Karnofsky Performance Status ; RTOG = Radiation Therapy Oncology Group ; SE = standard error ; STR = subtotal resection ; TMZ = temozolomide .
  • Collapse
  • Expand
  • 1

    Claus EB, , Horlacher A, , Hsu L, , Schwartz RB, , Dello-Iacono D, & Talos F, et al.: Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 103:12271233, 2005

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Curran WJ Jr, , Scott CB, , Horton J, , Nelson JS, , Weinstein AS, & Fischbach AJ, et al.: Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704710, 1993

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    Deorah S, , Lynch CF, , Sibenaller ZA, & Ryken TC: Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurg Focus 20:4 E1, 2006

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Ewelt C, , Goeppert M, , Rapp M, , Steiger HJ, , Stummer W, & Sabel M: Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol 103:611618, 2011

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Kubben PL, , ter Meulen KJ, , Schijns OE, , ter Laak-Poort MP, , van Overbeeke JJ, & van Santbrink H: Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol 12:10621070, 2011

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Lacroix M, , Abi-Said D, , Fourney DR, , Gokaslan ZL, , Shi W, & DeMonte F, et al.: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190198, 2001

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Laws ER, , Parney IF, , Huang W, , Anderson F, , Morris AM, & Asher A, et al.: Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99:467473, 2003

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    McGirt MJ, , Chaichana KL, , Gathinji M, , Attenello FJ, , Than K, & Olivi A, et al.: Independent association of extent of resection with survival in patients with malignant brain astrocytoma. Clinical article. J Neurosurg 110:156162, 2009

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Pichlmeier U, , Bink A, , Schackert G, & Stummer W: Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:10251034, 2008

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Sanai N, & Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753764, 2008

  • 11

    Sanai N, & Berger MS: Operative techniques for gliomas and the value of extent of resection. Neurotherapeutics 6:478486, 2009

  • 12

    Sanai N, , Polley MY, , McDermott MW, , Parsa AT, & Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:38, 2011

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Scott CB, , Scarantino C, , Urtasun R, , Movsas B, , Jones CU, & Simpson JR, et al.: Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40:5155, 1998

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Senft C, , Bink A, , Franz K, , Vatter H, , Gasser T, & Seifert V: Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12:9971003, 2011

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Smith JS, , Chang EF, , Lamborn KR, , Chang SM, , Prados MD, & Cha S, et al.: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:13381345, 2008

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Stummer W, , Pichlmeier U, , Meinel T, , Wiestler OD, , Zanella F, & Reulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392401, 2006

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Stummer W, , Reulen HJ, , Meinel T, , Pichlmeier U, , Schumacher W, & Tonn JC, et al.: Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 62:564576, 2008

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Stupp R, , Mason WP, , van den Bent MJ, , Weller M, , Fisher B, & Taphoorn MJ, et al.: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987996, 2005

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Surawicz TS, , Davis F, , Freels S, , Laws ER Jr, & Menck HR: Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40:151160, 1998

Metrics

All Time Past Year Past 30 Days
Abstract Views 6804 1515 169
Full Text Views 1339 132 17
PDF Downloads 885 153 25
EPUB Downloads 0 0 0